SG11201913229PA - Silk-hyaluronic acid based tissue fillers and methods of using the same - Google Patents

Silk-hyaluronic acid based tissue fillers and methods of using the same

Info

Publication number
SG11201913229PA
SG11201913229PA SG11201913229PA SG11201913229PA SG11201913229PA SG 11201913229P A SG11201913229P A SG 11201913229PA SG 11201913229P A SG11201913229P A SG 11201913229PA SG 11201913229P A SG11201913229P A SG 11201913229PA SG 11201913229P A SG11201913229P A SG 11201913229PA
Authority
SG
Singapore
Prior art keywords
silk
methods
same
hyaluronic acid
acid based
Prior art date
Application number
SG11201913229PA
Other languages
English (en)
Inventor
Gregory H Altman
Peng Xu
Erlei Jin
Original Assignee
Evolved By Nature Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolved By Nature Inc filed Critical Evolved By Nature Inc
Publication of SG11201913229PA publication Critical patent/SG11201913229PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201913229PA 2017-06-26 2018-06-26 Silk-hyaluronic acid based tissue fillers and methods of using the same SG11201913229PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762525131P 2017-06-26 2017-06-26
US201862641095P 2018-03-09 2018-03-09
PCT/US2018/039574 WO2019005848A1 (en) 2017-06-26 2018-06-26 HYALURONIC SILK ACID TISSUE FILLING AGENTS AND METHODS OF USE THEREOF

Publications (1)

Publication Number Publication Date
SG11201913229PA true SG11201913229PA (en) 2020-01-30

Family

ID=64742709

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201913229PA SG11201913229PA (en) 2017-06-26 2018-06-26 Silk-hyaluronic acid based tissue fillers and methods of using the same

Country Status (14)

Country Link
US (1) US20230338614A1 (de)
EP (2) EP4169539A1 (de)
JP (2) JP2020525253A (de)
KR (1) KR20200032103A (de)
CN (1) CN111263646A (de)
AU (2) AU2018290810C1 (de)
CA (1) CA3068296A1 (de)
CO (1) CO2020000774A2 (de)
ES (1) ES2935887T3 (de)
IL (2) IL299584A (de)
MA (1) MA49520A (de)
SG (1) SG11201913229PA (de)
UA (1) UA127350C2 (de)
WO (1) WO2019005848A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660372B2 (en) 2017-06-26 2023-05-30 Evolved By Nature, Inc. Silk-hyaluronic acid based tissue fillers and methods of using the same

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6508431B1 (ja) 2017-09-21 2019-05-08 住友電気工業株式会社 半絶縁性ヒ化ガリウム結晶基板
BR112021012141A2 (pt) * 2018-12-19 2021-08-31 Evolved By Nature, Inc. Preenchimento de tecido biocompatível, método de tratamento de uma condição em um sujeito em necessidade do mesmo e método de tratamento cosmético em um sujeito em necessidade do mesmo
WO2020205774A1 (en) * 2019-03-29 2020-10-08 Trustees Of Tufts College Crosslinked silk fibroin-based compositions, and methods of making and using the same
JP2022534802A (ja) * 2019-06-06 2022-08-03 エボルブド バイ ネイチャー， インコーポレイテッド 絹で刺激されたコラーゲンの製造、及びその使用方法
EP3990295B1 (de) * 2019-06-26 2023-10-04 Compagnie Generale Des Etablissements Michelin Geräuschverbessernde lauffläche
CN110339398A (zh) * 2019-07-18 2019-10-18 王月玲 一种含氨基酸透明质酸钠注射剂及其制备方法
WO2021035087A1 (en) * 2019-08-20 2021-02-25 Evolved By Nature, Inc. Silk personal care compositions
EP3995530A4 (de) * 2019-09-27 2022-08-31 LG Chem, Ltd. Verfahren zur herstellung von polymermikropartikeln, polymermikropartikel, medizinische zusammensetzung damit, kosmetische zusammensetzung, medizinischer artikel und kosmetischer artikel
EP4077402B1 (de) * 2019-12-19 2024-05-01 Croma-Pharma GmbH Thiolmodifiziertes hyaluronan und hydrogel mit dem vernetzten hyaluronan
CA3183134A1 (en) * 2020-06-19 2021-12-23 Gregory H. Altman Silk-hyaluronic acid compositions for tissue filling, tissue spacing, and tissue bulking
CN116507315A (zh) * 2020-06-19 2023-07-28 自然进化公司 用于组织填充、组织间隔和组织膨胀的丝-透明质酸组合物
CN114213517B (zh) * 2021-02-08 2024-07-09 复向丝泰医疗科技(苏州)有限公司 利用切向流超滤技术制备可控高浓度丝素蛋白溶液的方法
US11585016B2 (en) 2021-05-21 2023-02-21 Cambridge Crops, Inc. Systems and methods for manufacturing a silk fibroin solution and powders containing silk fibroin
EP4362993A1 (de) * 2021-06-30 2024-05-08 Merz Pharma GmbH & Co. KGaA Mit polyethylenglykoldiglycidylether vernetzter hautfüller auf hyaluronsäure, herstellungsverfahren dafür und verwendungen davon
CN113368220A (zh) * 2021-07-05 2021-09-10 云南维他源生物科技有限公司 一种ahco组合物及其制剂与应用
KR20230013682A (ko) 2021-07-16 2023-01-27 주식회사 휴메딕스 Pegde로 가교된 히알루론산 필러 및 이의 제조방법
US11864569B2 (en) 2021-08-16 2024-01-09 Cambridge Crops, Inc. Systems and methods for improving the performance of cereal using a silk fibroin solution and powders containing silk fibroin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH538003A (fr) 1968-03-29 1973-01-31 Anvar Procédé pour l'obtention d'articles textiles porteurs d'enzymes
FR2334107A1 (fr) 1975-12-05 1977-07-01 Pasteur Institut Procede de couplage de substances biologiques par des liaisons covalentes
US4355023A (en) 1980-09-30 1982-10-19 The Massachusetts General Hospital Antibody fragment compositions and process
US4657853A (en) 1984-09-14 1987-04-14 E. I. Du Pont De Nemours And Company Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US20110189292A1 (en) * 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
EP2498830B1 (de) * 2009-11-11 2016-09-21 University of Twente, Institute for Biomedical Technology and Technical Medicine (MIRA) Hydrogels auf Basis von Dextran-Hyaluronsäure
JP6009550B2 (ja) * 2011-06-03 2016-10-19 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 抗酸化物質を含む皮膚充填剤組成物
KR20200116168A (ko) * 2011-09-14 2020-10-08 알러간, 인코포레이티드 잔주름 치료를 위한 진피 필러 조성물
CN102836465B (zh) * 2012-08-30 2014-06-04 浙江星月生物科技股份有限公司 一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用
WO2014055895A1 (en) * 2012-10-05 2014-04-10 Allergan, Inc. Injectable device and method for sculpting, augmenting or correcting facial features such as the chin
US20140315828A1 (en) * 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
JP6479783B2 (ja) 2013-06-28 2019-03-06 ガルデルマ エス．エー． 架橋ヒアルロン酸生成物を調製するための方法
KR102379848B1 (ko) 2013-09-30 2022-03-28 실크 테라퓨틱스, 인코퍼레이티드 실크 단백질 단편 조성물 및 이로부터 제작된 물품
EA035551B1 (ru) 2014-12-02 2020-07-06 Силк Терапьютикс, Инк. Изделие
CA2984433A1 (en) * 2015-04-29 2016-11-03 Silk Therapeutics, Inc. Silk-based moisturizer compositions and methods thereof
US10175996B2 (en) 2016-05-02 2019-01-08 Norman R. Byrne Information display and control for work areas
EP3503841A4 (de) * 2016-08-24 2020-04-22 Allergan, Inc. Covernetzte hyaluronsäure-seidenfibroin-hydrogele zur verbesserung der lebensfähigkeit von gewebetransplantaten und weichteilaugmentation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660372B2 (en) 2017-06-26 2023-05-30 Evolved By Nature, Inc. Silk-hyaluronic acid based tissue fillers and methods of using the same

Also Published As

Publication number Publication date
UA127350C2 (uk) 2023-07-26
CO2020000774A2 (es) 2020-05-05
CN111263646A (zh) 2020-06-09
EP3645063A4 (de) 2021-04-14
WO2019005848A1 (en) 2019-01-03
ES2935887T3 (es) 2023-03-13
IL271692A (en) 2020-02-27
AU2024219582A1 (en) 2024-10-03
AU2018290810B2 (en) 2024-06-13
EP3645063B1 (de) 2022-09-28
JP2023139249A (ja) 2023-10-03
BR112019027687A2 (pt) 2020-09-15
KR20200032103A (ko) 2020-03-25
IL271692B2 (en) 2023-06-01
CA3068296A1 (en) 2019-01-03
AU2018290810A1 (en) 2020-02-13
EP3645063A1 (de) 2020-05-06
MA49520A (fr) 2021-04-14
AU2018290810C1 (en) 2024-09-12
JP2020525253A (ja) 2020-08-27
EP4169539A1 (de) 2023-04-26
IL299584A (en) 2023-03-01
US20230338614A1 (en) 2023-10-26

Similar Documents

Publication Publication Date Title
IL271692A (en) Tissue fillers based on hyaluronic acid and silk and methods of using them
IL268406A (en) Preparations and methods for treating hemoglobin diseases
HK1258205A1 (zh) 用於治療血紅蛋白病的組合物和方法
EP3474785A4 (de) Wirbelsäulenimplantat und verfahren zur verwendung davon
EP3432933A4 (de) Biokompatible haftstoffe und verfahren zur verwendung davon
EP3356517A4 (de) Spontan schlagende herzorganoidkonstrukte und integrierte körper-auf-chip-vorrichtung damit
EP3303634A4 (de) Cas9-varianten und verfahren zur verwendung davon
EP3397149A4 (de) Gewebekartierung und behandlung
EP3325473A4 (de) Verbindungen und verwendungen davon in der behandlung von krebs und anderen medizinischen störungen
HK1253769A1 (zh) 用於診斷和治療腎上腺腦白質營養不良的方法和組合物
GB201513461D0 (en) Methods and devices for the production of decellularised tissue scaffolds
IL284082A (en) Silk-hyaluronic acid tissue fillers and methods for their preparation and use
EP3185795A4 (de) Knochenfixiervorrichtungen und verfahren
EP3242709A4 (de) Herzstimulation von vorhof-ventrikelpfaden und/oder zugehörigem gewebe
EP3154533A4 (de) Verfahren zur betäubung des nervengewebes im drillingsnervenpfad und medizinische verwendungen davon
EP3474869A4 (de) Zusammensetzungen aus menschlichem gewebe und verwendungen davon
IL275182A (en) Preparations and methods for the treatment of metabolic conditions
EP3224362A4 (de) Therapeutische zusammensetzungen mit transkriptionsfaktoren sowie verfahren zur herstellung und verwendung davon
IL272937A (en) Preparations and methods for the treatment of diseases involving fibrosis
EP3496804A4 (de) Bioelektrische vorrichtungen und verfahren zur verwendung
EP3209340A4 (de) Mikrofabrizierte gewebegerüste und verfahren zur herstellung und verwendung davon
IL248210A0 (en) Methods and preparations for the treatment of blood vessel malformations
GB201709840D0 (en) Methods and medical uses
EP3341006A4 (de) Zusammensetzungen und verfahren zur behandlung von nervenschäden
ZA201900984B (en) Methods and compositions for the treatment of warts